FDA Takes New Steps to Mitigate Opioid Overprescribing FDA Takes New Steps to Mitigate Opioid Overprescribing
The the US Food and Drug Administration has released a revised blueprint containing core content for training that drug manufacturers are required to make available to opioid prescribers.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news
More News: Food and Drug Administration (FDA) | Health | Psychiatry | Training | Universities & Medical Training